Skip to main content
← Back to work

Works cited by this work

161 works

Work: Engineering CAR T NK and NKT cell therapies to target cancer stem cells and overcome stem like resistance

  1. Cancer stem cells and their niche in cancer progression and therapy

    Qiuping Liu, Zongliang Guo, Guoyin Li +5

    Review article20233 citations
    ABI
  2. Programmed cell death and melatonin: A comprehensive review

    Mahdi Rafiyian, Rüssel J. Reiter, Sayyed Mehdi Rasooli Manesh +5

    Review article20243 citations
    ABI
  3. Metabostemness: A New Cancer Hallmark

    Javier A. Menéndez, Tomás Alarcà n

    Review article20143 citations
    ABI
  4. The Basic Principles of Chimeric Antigen Receptor Design

    Michel Sadelain, Renier J. Brentjens, Isabelle Rivière

    Review article20133 citations
    ABI
  5. Cancer stem cells revisited

    Eduard Batlle, Hans Clevers

    Review article20173 citations
    ABI
  6. Engineering and Design of Chimeric Antigen Receptors

    Sònia Guedan, Hugo Calderón, Avery D. Posey +1

    Review article20183 citations
    ABI
  7. Targeting Cancer Stem Cells by Genetically Engineered Chimeric Antigen Receptor T Cells

    Rowa Y. Alhabbab

    Review article20203 citations
    ABI
  8. Ferroptosis: molecular mechanisms and health implications

    Daolin Tang, Xin Chen, Rui Kang +1

    Review article20203 citations
    ABI
  9. CAR-T Cell Therapy for Breast Cancer: From Basic Research to Clinical Application

    Yu-Huan Yang, Jiawei Liu, Lü Chen +1

    Review article20223 citations
    ABI
  10. Cancer cell targeting by CAR-T cells: A matter of stemness

    Caterina D’Accardo, Gaetana Porcelli, Laura Rosa Mangiapane +10

    Review article20223 citations
    ABI
  11. Precision sniper for solid tumors: CAR-NK cell therapy

    Sisi Li, Jiajie Jing, Yueming Chen +6

    Review article20253 citations
    ABI
  12. Optimization of metabolism to improve efficacy during CAR-T cell manufacturing

    Meng Zhang, Xin Jin, Rui Sun +4

    Review article20212 citations
    ABI
  13. Preclinical and clinical studies of CAR-NK-cell therapies for malignancies

    Hongwen Li, Wenting Song, Zhaoming Li +1

    Review article20222 citations
    ABI